Skip to main content
NCBI home page
Heliyon logoLink to Heliyon
. 2021 Apr 11;7(4):e06767. doi: 10.1016/j.heliyon.2021.e06767

A short review, effect of dimethyl-β-cyclodextrin on the interaction between Helicobacter pylori and steroidal compounds

Kiyofumi Wanibuchi a, Kouichi Hosoda b,1, Avarzed Amgalanbaatar c,1, Yoshikazu Hirai d, Mitsuru Shoji a, Hirofumi Shimomura e,∗
PMCID: PMC8065201  PMID: 33912723

Abstract

The 2,6-di-O-methyl-β-cyclodextrin (dMβCD) is an amphiphilic annular compound consisting of seven dimethyl-glucose molecules. This compound is well known as a solubilizer of lipophilic compounds. Especially, dMβCD extracts cholesterol from the plasma membrane of mammalian cells and releases the cholesterol to the aqueous solution. The experimental use of dMβCD, therefore, serves to investigate the role of cholesterol in the mammalian cell membrane. It is, however, unclear as to how dMβCD extracts cholesterol incorporated into the glycerophospholipid biomembrane. Meanwhile, dMβCD acts as a beneficial compound for Helicobacter pylori and is used as the standard component for supporting the growth of this bacterium in the serum-free culture. However, the detailed mechanism of dMβCD for supporting the growth of H. pylori is still to be clarified. H. pylori is a Gram-negative microaerophilic bacillus recognized as a pathogen concerned with gastrointestinal diseases in human. Previous studies by our group have successfully obtained the H. pylori strains culturable without dMβCD and demonstrated the distinct effects of dMβCD on the interaction between H. pylori and exogenous steroidal compounds. For instance, dMβCD promotes and inhibits the absorption of cholesterol and several steroidal compounds respectively into the biomembranes of H. pylori. In this study we summarized behaviors of dMβCD toward steroidal compounds relevant to H. pylori.

Keywords: Dimethyl-β-cyclodextrin, Phosphatidylethanolamine, Cholesterol, Steroid hormone, Helicobacter pylor

Dimethyl-β-cyclodextrin; Phosphatidylethanolamine; Cholesterol; Steroid hormone; Helicobacter pylori

1. Introduction

A cyclic compound 2,6-di-O-methyl-β-cyclodextrin (dMβCD) is comprised of seven dimethyl-glucose molecules that are linked by α(1→4) bonding and takes the conformation like a bottomless cup of trapezoid (Figure 1). This compound is amphiphilic and solubilizes lipophilic compounds in aqueous solution. Lipophilic compounds such as flavonoid glycosides, sodium salicylate and ibuprofen are considered to be embedded into the inside of ring of dMβCD molecule and to form the molecular inclusion complexes at the molar ratio of 1:1 [1, 2, 3, 4]. In particular, cholesterol is well known as the most suitable “guest molecule” for dMβCD [5, 6, 7, 8, 9]. A previous study by other group has demonstrated that the molecular inclusion complexes comprising of cholesterol and dMβCD are more predominant at the molar ratio of 1:2 rather than 1:1 [10]. As one of the behaviors of dMβCD toward the mammalian cell membrane, this annular compound extracts cholesterol from the plasma membrane lipid constituents. The experimental use of dMβCD, therefore, serves to investigate the role of cholesterol in the mammalian cell membrane, although it is unclear as to how dMβCD extracts cholesterol incorporated into the glycerophospholipid biomembrane.

Figure 1.

Figure 1

Open in a new tab

Chemical structure of dMβCD.

Of the βCDs, hydroxypropyl-β-CD (HPβCD) has been attracting attention as a therapeutic medication for Neiman-Pick disease, type C1 (NPC1) [11]. NPC1 is an autosomal recessive inherited disease and causes hepatosplenomegaly and progressive neuropathy in childhood. Patients (children) with NPC1 abnormally accumulate nonesterified cholesterol and sphingoglycolipids to the intracellular lysosome. HPβCD decreases neurological disease progression in NPC1 though its detailed mechanism is still to be clarified. In addition, lactosyl-β-CD (LacβCD) has been demonstrated to effectively reduce the intracellular cholesterol levels in NPC-like HepG2 cells [12]. Differing from dMβCD, HPβCD and LacβCD turned out to be useful for the treatment of patients with NPC1.

In eukaryote cells, dMβCD is considered to be a toxic compound that induces the membrane lipid conformational disorder by dissociating cholesterol from the plasma membrane [13]. Meanwhile, dMβCD is a beneficial compound for Helicobacter pylori that is a pathogen responsible for peptic ulcers and gastric cancers in human [14]. In the serum-free culture, H. pylori actively grows in the medium supplemented with dMβCD (0.1–0.2%) [15, 16]. Though the detailed mechanism of dMβCD for supporting the growth of H. pylori is not fully understood, dMβCD is considered to scavenge toxic lipophilic compounds contained in the culture medium [17].

A previous study by our group successfully obtained the H. pylori strains that had been acclimatized to the culture medium without either serum or dMβCD, and we invented the interesting effects of dMβCD on the membrane responses of H. pylori to exogenous steroidal compounds using those strains [18, 19, 20, 21]. In this review we summarize the unique effect of dMβCD on the interaction between H. pylori and exogenous steroidal compounds based on the results obtained so far.

2. Interaction of dMβCD with lipophilic compounds

2.1. Phosphatidylethanolamine

The biomembranes of Gram-negative bacteria including H. pylori are constructed with the inner and outer membranes. In general the inner membrane is comprised of phosphatidylethanolamine (PE), phosphatidylglycerol (PG), and cardiolipin (CL). Meanwhile, the outer membrane is comprised of PE, PG, CL, and lipopolysaccharide (LPS). LPS is a glycolipid consisting of hydrophobic portion called lipid A, inner core saccharide-chain, outer core saccharide-chain, and O-polysaccharide-chain. LPS localizes to the outermost layer of the outer membrane [22, 23, 24, 25, 26]. The O-polysaccharide-chain takes role of directly contact with outside the bacterial cells and regulates the membrane permeability of hydrophobic compounds. PE is the most predominant glycerophospholipid of Gram-negative bacterial membrane lipid constituents. A previous study by our group has revealed that the fatty acid composition of PE of H. pylori considerably differs from that of the typical Gram-negative bacterial PE such as Escherichia coli PE. After the total lipids were extracted from the biomembranes of either H. pylori or E. coli by the organic solvent distribution method, PE was purified from the total lipids by the silica gel-column chromatography, and the fatty acid composition of the purified PE was analyzed by the gas chromatography-mass spectrometry (GC-MS). As a consequence, the saturated fatty acid side-chain of H. pylori PE is myristate (14:0) whereas the saturated fatty acid side-chain of E. coli PE is palmitate (16:0) [21,27]. In addition, the high performance liquid chromatography-mass spectrometry (LC-MS) analysis showed that PE molecular species of H. pylori are almost composed of the three PE molecular species with the fatty acid combination of myristate/19:0 cyclopropanoic acid (34.5%), myristate/myristate (28.9%), and myristate/oleate (18:1) (15.0%). Meanwhile, the predominant PE molecular species of E. coli were comprised of the fatty acid combination of palmitate/17:0 cyclopropanoic acid (25.7%), palmitate/oleate (14.7%), and palmitate/palmitoleate (16:1) (14.7%). Moreover, we have demonstrated that dimyristoyl-PE as one of the most prevalent PE molecular species of H. pylori selectively interacts not with cholesterol ester but with cholesterol [21].

After cholesterol-free H. pylori and E. coli at 109 colony-forming units (CFU)/ml were incubated for 4 h in the presence of dMβCD (5 mM) in the culture medium (5 ml) and were washed three times with PBS, the dMβCD bound to either H. pylori or E. coli was quantified using the phenol-sulfuric acid method. As a consequence, the detection levels of dMβCD in the cholesterol-free H. pylori cells were approximately 6.5 nmol/109 CFU. However, the detection levels of dMβCD in the E. coli cells were less than 1 nmol/109 CFU. In sum, H. pylori cells turned out to tightly bind to dMβCD [21]. We next examined the binding-affinity of dMβCD for either H. pylori PE or E. coli PE using paper disks that had fixed several amounts of PE (100–300 μg). After the PE-fixed paper disks were soaked for 4 h in the buffer (2 ml) containing dMβCD (5 mM) and were washed six times with distilled water, dMβCD extracted from the PE-fixed paper disks were quantified using phenol-sulfuric acid method. As a consequence, the amounts of dMβCD increased along with the increase of H. pylori PE amount fixed to the paper disk. However, the amounts of dMβCD were negligible regardless of the increase of E. coli PE amount fixed to the paper disk. In sum, dMβCD turned out to show high binding-affinity not for E. coli PE but for H. pylori PE (Figure 2). Though the selective binding-affinity of dMβCD for H. pylori PE may be relevant to the myristate of the PE molecular species, the detailed mechanism of it is unknown.

Figure 2.

Figure 2

Open in a new tab

Interaction of dMβCD with the membranal PE of either H. pylori or E. coli.

2.2. Cholesterol

H. pylori aggressively absorbs exogenous cholesterol into the biomembranes and uses the cholesterol as one of the membrane lipid constituents [19, 28, 29, 30, 31, 32, 33, 34, 35]. The assimilation of cholesterol into the biomembranes is a unique biological feature of this bacterium. In a previous study we examined the effect of dMβCD on the cholesterol absorption in H. pylori [21]. Cholesterol-free H. pylori (106 CFU/ml) was cultured for 24 h in the presence of cholesterol-coating beads (250 μM as cholesterol) in the medium (30 ml) supplemented with or without dMβCD (0.2%). After the bacterial cells (108 CFU) were recovered, the lipids were extracted from the bacterial cells by the organic solvent distribution method, and cholesterol was quantified using the ferrous chloride-sulfuric acid method. Intriguingly, the cholesterol contents were only approximately 2% of whole lipids (excluding LPS) in H. pylori cultured in the absence of dMβCD whereas were approximately 10.5% of whole lipids (excluding LPS) in H. pylori cultured in the presence of dMβCD. These results indicate that the cholesterol-inclusion dMβCD delivers cholesterol to H. pylori through the intermediation of the membranal myristoyl-PE and promotes the cholesterol absorption of H. pylori (Figure 3).

Figure 3.

Figure 3

Open in a new tab

Relationship between cholesterol, dMβCD, and H. pylori.

2.3. 3β-hydroxyl steroids

In addition to cholesterol, H. pylori also assimilates the 3β-hydroxyl steroids such as pregnenolone and dehydroepiandrosterone into the biomembranes [18]. These steroidal compounds are also considered to be incorporated into the H. pylori biomembranes at least through the intermediation of the dimyristoyl-PE [21]. However, the interaction of dMβCD with the 3β-hydroxyl steroids completely differs from that of dMβCD with cholesterol. Either cholesterol-free H. pylori or E. coli at 109 CFU/ml was incubated for 4 h together with cholesterol (100 nmol)-fixed paper disk in the presence or absence of dMβCD (5 mM) in the culture medium (5 ml). After the bacterial cells were recovered and were washed three times with PBS, the lipids were extracted from the bacterial cells by the organic solvent distribution method, and cholesterol contained in the lipids was quantified using the ferrous chloride-sulfuric acid method. Intriguingly, cholesterol (approximately 4.5 nmol) was detected only in the lipids of H. pylori incubated with cholesterol-fixed paper disk in the presence of dMβCD. These results indicate that H. pylori is incapable of directly extracting cholesterol from the paper disk, and that dMβCD solubilizes cholesterol fixed to the paper disk and delivers the cholesterol to H. pylori through the intermediation of the membranal myristoyl-PE.

The same experiments as mentioned above were carried out using either pregnenolone-fixed paper disk or dehydroepiandrosterone-fixed paper disk in place of cholesterol-fixed paper disk [21]. Surprisingly, pregnenolone and dehydroepiandrosterone were detected at approximately 10 nmol and 7 nmol respectively in the lipids of H. pylori (109 CFU) not in the presence of dMβCD (5 mM) but in the absence of it. These results indicate that H. pylori absorbs those steroids spontaneously eluted from the paper disks, and that the membrane absorption of those steroids is completely inhibited by the action of dMβCD (Figure 4). Though it is unclear as to why dMβCD promotes the cholesterol absorption of H. pylori and inhibits the 3β-hydroxyl steroid absorption of this bacterium, the differences of molecular weights of the guest molecules for dMβCD may affect the membrane absorption of steroidal compounds in H. pylori. The molecular weights of cholesterol, pregnenolone, and dehydroepiandrosterone are 386.654, 316.4776, and 288.424, respectively. On this basis, relatively low-molecular-weight steroids may be more deeply embedded into the inside of ring structure of dMβCD than cholesterol and may be difficult to dissociate from dMβCD. In addition, the steroid-inclusion dMβCD may be unable to bind to the myristoyl-PE of the H. pylori outer membrane by a certain factor such as the conformational structure of molecular inclusion complexes. Further investigations will need to solve the enigma as for the relationship between H. pylori myristoyl-PE and cholesterol-inclusion dMβCD or steroid-inclusion dMβCD.

Figure 4.

Figure 4

Open in a new tab

Relationship between 3β-OH and 3-OH steroids, dMβCD, and H. pylori.

2.4. Progesterone and its derivatives

Previous studies by our group have demonstrated that progesterone, 17α-hydroxyprogesterone caproate, and 17α-hydroxyprogesterone linoleate confer the selective bactericidal action to H. pylori. The minimum inhibitory concentrations (MIC) of progesterone, 17α-hydroxyprogesterone caproate, and 17α-hydroxyprogesterone linoleate for the cholesterol-free H. pylori strain measured by the conventional agar-plate dilution method were the 50, 3, and 1 μM, respectively [19, 20, 34]. In addition, when the minimum bactericidal concentrations (MBC) were estimated by the conventional serial-dilution method, the MBC of 17α-hydroxyprogesterone linoleate for the three cholesterol-absorbing H. pylori strains that had been continuously acclimatized to the culture medium supplemented with cholesterol (30 μM) were the ranging of 4–24 μM [27]. Meanwhile, these progestins have no influence on the viability of representative bacteria such as Enterobacteriaceae bacteria (the five bacterial species), Pseudomonas aeruginosa, and genus Staphylococcus [19, 20, 27, 34]. Therefore, the MIC or MBC of those progestins for the above bacterial species were greater than the 100 μM. Progesterone and its derivatives are considered to act on the myristoyl-PE of H. pylori biomembranes and to induce the bacteriolysis to this bacterium [27].

We examined the effect of dMβCD on the bactericidal activity of the three progestins against H. pylori. When cholesterol-free H. pylori (105.5 CFU/ml) were cultured for 24 h in the presence or absence of progesterone (50 μM) in the medium (1 ml) supplemented with dMβCD (0.2%), progesterone had no influence on the viability of H. pylori and therefore the bacteria grew to 108 CFU/ml even in the presence of progesterone (50 μM) as similar to the absence of it [18]. Meanwhile, the cholesterol-free H. pylori in the absence of dMβCD succumbed to the bactericidal action of progesterone (50 μM), and therefore the viability of the bacteria decreased from 105.5 CFU/ml to 104 CFU/ml [19]. In sum, dMβCD turned out to completely inhibit the bactericidal activity of progesterone against H. pylori (Figures 5 and 6). Similarly, when the cholesterol-free H. pylori (106.5 CFU/ml) was cultured for 24 h in the presence of 17α-hydroxyprogesterone caproate (6 μM) in the medium (1.5 ml) supplemented with or without dMβCD (30 μM), H. pylori without dMβCD was almost completely eradicated by the action of 17α-hydroxyprogesterone caproate [34]. However, dMβCD protected the cholesterol-free H. pylori from the bactericidal action of 17α-hydroxyprogesterone caproate, and the viability of H. pylori was maintained the 106.5 CFU/ml that is the baseline CFU levels immediately before the start of experiment. In contrast, dMβCD had no effect on the bactericidal action of 17α-hydroxyprogesterone linoleate against the cholesterol-free H. pylori (Figure 7). Hence, 17α-hydroxyprogesterone linoleate (6 μM) completely eradicated H. pylori (106.5 CFU/ml) by 24 h regardless of the presence or absence of dMβCD (30 μM). However, dMβCD did not involve in the augmentation of the bactericidal activity of 17α-hydroxyprogesterone linoleate against H. pylori.

Figure 5.

Figure 5

Open in a new tab

Relationship between progesterone, dMβCD, and H. pylori.

Figure 6.

Figure 6

Open in a new tab

Relationship between 17α-hydroxyprogesterone caproate, dMβCD, and H. pylori.

Figure 7.

Figure 7

Open in a new tab

Relationship between 17α-hydroxyprogesterone linoleate, dMβCD, and H. pylori.

We next examined the effect of dMβCD on the interaction between H. pylori PE and 17α-hydroxyprogesterone caproate or 17α-hydroxyprogesterone linoleate [27, 34]. The H. pylori PE (200 μg)-fixed paper disk was soaked for 2 h in the presence of dMβCD (3 mM) in the buffer (2 ml) containing either 17α-hydroxyprogesterone caproate (100 μM) or 17α-hydroxyprogesterone linoleate (100 μM or 30 μM). After the PE-fixed paper disk was washed six times with distilled water (2 ml), the 17α-hydroxyprogesterone caproate and 17α-hydroxyprogesterone linoleate bound to the PE fixed to the paper disks were analyzed by thin-layer chromatography. As a consequence, 17α-hydroxyprogesterone linoleate was detected at high density whereas no 17α-hydroxyprogesterone caproate was detected. These results indicate that dMβCD inhibits the binding of 17α-hydroxyprogesterone caproate to H. pylori PE but has no inhibition effect on the binding of 17α-hydroxyprogesterone linoleate to H. pylori PE. On this basis, dMβCD is considered to inhibit the bactericidal action of progesterone and 17α-hydroxyprogesterone caproate against H. pylori by preventing the binding of those progestins to the myristoyl-PE of the biomembranes.

The molecular weight of progesterone is 314.46 and is lower than the molecular weight of cholesterol. Therefore, progesterone may be unable to interact with the myristoyl-PE of H. pylori biomembranes by being deeply embedded to the inside of ring of dMβCD molecule. In addition, the progesterone-inclusion dMβCD as similar to the other steroid-inclusion dMβCD also may be unable to tightly bind to the myristoyl-PE of H. pylori biomembranes. However, 17α-hydroxyprogesterone caproate was excluded from the above hypothesis, because the molecular weight (428.6041) of this progesterone derivative is higher than that (386.654) of cholesterol. As mentioned earlier, the inhibition effect of dMβCD (30 μM) was incomplete on the bactericidal action of 17α-hydroxyprogesterone caproate (6 μM) against H. pylori (106.5 CFU/ml) since the bacteria were not eradicated and maintained the baseline CFU levels (106.5 CFU/ml), though dMβCD (3 mM) inhibited the interaction between H. pylori PE (200 μg) and 17α-hydroxyprogesterone caproate (100 μM). These results may mean that the short alkyl chain (6:0) of the 17α-hydroxyprogesterone caproate is an important structure that affects the dissociation of its molecule from the dMβCD molecules and inhibits the tightly binding of the inclusion complexes to the myristoyl-PE of H. pylori biomembranes. Further investigations will be necessary to elucidate the detailed mechanism of dMβCD for inhibiting the bactericidal action of progesterone and 17α-hydroxyprogesterone caproate against H. pylori. Meanwhile, the molecular weight of 17α-hydroxyprogesterone linoleate is 576.892 and is higher than that of cholesterol. This suggests the possibility that dMβCD delivers 17α-hydroxyprogesterone linoleate to H. pylori by forming the baggy inclusion complexes due to the high molecular weight of its progesterone derivative.

3. Conclusions

In this review we described the following interactions between dMβCD, steroidal compounds, and H. pylori myristoyl-PE: (1) dMβCD tightly binds to the myristoyl-PE of H. pylori biomembranes; (2) dMβCD promotes the absorption of cholesterol into the H. pylori biomembranes; (3) dMβCD inhibits the absorption of relatively low-molecular-weight steroids into the H. pylori biomembranes; (4) dMβCD protects H. pylori from the bactericidal action of progesterone and 17α-hydroxyprogesterone caproate; (5) dMβCD has no effect on the bactericidal action of 17α-hydroxyprogesterone linoleate against H. pylori. However, there are still a number of enigmas as to either how dMβCD delivers the steroidal compounds to the biomembranes of H. pylori or how dMβCD selectively prevents the binding of several steroidal compounds to the biomembranes of H. pylori.

Earlier studies by our group have demonstrated that progesterone and its derivatives confer the selective bactericidal action to H. pylori without affecting the viability of typical bacterial species [27]. These results suggest that anti-H. pylori drugs are capable of being developed using progesterone as the fundamental structure. However, as a number of steroidal compounds is hydrophobicity, it is pharmacologically important to give hydrophilicity to the steroidal drugs designed to more effectively exert the anti-H. pylori action. One of the interesting findings is that progesterone derivative with relatively high-molecular-weight acts as a bactericidal agent on H. pylori even in the presence of dMβCD. On this basis, the progesterone derivatives covalently linked to dMβCD may have amphiphilic property and act as a novel antibacterial drug for selectively eradicating H. pylori without collapsing the balance of intestinal microbiota. A previous study by other group has demonstrated that progesterone has beneficial effect on gastritis of ovarectomized female gerbils infected with H. pylori [36]. It was, however, unclear as to whether progesterone has influence on the viability of H. pylori colonized stomach of the gerbils. In the future we will synthesize dMβCD-linked progesterone derivatives and need to evaluate the anti-H. pylori activity of its newly progesterone derivatives in vitro and in vivo. In addition, we will try to examine in vivo pharmacokinetics of dMβCD-linked progesterone derivatives using the combinations of the gas chromatography-quadrupole time of flight mass spectrometry (GC-Q-TOF/MS) and the liquid chromatography-quadrupole time of flight mass spectrometry (LC-Q-TOF/MS) [37].

Declarations

Author contribution statement

All authors listed have significantly contributed to the development and the writing of this article.

Funding statement

This work was supported by a JSP KAKENHI (grant number 25460544), and JKA promotion funds from KEIRIN RACE.

Data availability statement

No data was used for the research described in the article.

Declaration of interests statement

The authors declare no conflict of interest.

Additional information

No additional information is available for this paper.

Acknowledgements

This work was supported by a JSP KAKENHI (grant number 25460544), and JKA promotion funds from KEIRIN RACE.

References

  • 1.Ohtani Y., Irie T., Uekama K., Fukunaga K., Pitha J. Differential effects of alpha-, beta-, and gamma-cyclodextrins on human erythrocytes. Eur. J. Biochem. 1989;186:17–22. doi: 10.1111/j.1432-1033.1989.tb15171.x. [DOI] [PubMed] [Google Scholar]
  • 2.Junquera E., Pena L., Aicart E. Binding of sodium salicylate by β-cyclodextrin or 2,6-di-O-methyl-β-cyclodextrin in aqueous solution. J. Pharmacol. Sci. 1998;87:86–90. doi: 10.1021/js970117u. [DOI] [PubMed] [Google Scholar]
  • 3.Yu Z., Cui M., Yan C., Song F., Liu Z., Liu S. Investigation of heptalis(2,6-di-O-methyl)-β-cyclodextrin inclusion complexes with flavonoid glycosides by electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2007;21:683–690. doi: 10.1002/rcm.2883. [DOI] [PubMed] [Google Scholar]
  • 4.Nurhidayah E.,S., Martoprawiro M.,A., Zulfikar M.,A. PM3 and oniom2 modeling of inclusion complex of ibuprofen enantiomers with dimethyl-β-cyclodextrin. J. Chem. Tec. Metal. 2019;54:673–678. [Google Scholar]
  • 5.Fukasawa M., Nishijima M., Itabe H., Takano T., Hanada K. Reduction of sphingomyelin level without accumulation of ceramide in Chinese hamster ovary cells affects detargent-resistant membrane domain and enhances cellular cholesterol efflux to methyl-beta-cyclodextrin. J. Biol. Chem. 2000;275:34028–34034. doi: 10.1074/jbc.M005151200. [DOI] [PubMed] [Google Scholar]
  • 6.Yamashita T., Yamaguchi T., Murakami K., Nagasawa S. Detargent-resistant membrane domains are required for mast cell activation but dispensable for tyrosine phosphorylation upon aggregation for the high affinity receptor for IgE. J. Biochem. 2001;129:861–868. doi: 10.1093/oxfordjournals.jbchem.a002930. [DOI] [PubMed] [Google Scholar]
  • 7.Ohkubo S., Kotani A., Nakahata N. Lipid raft domains in NG108-15 cells; the role in P2Y2 receptor-mediated intracellular Ca2+ mobilization. Pharmacologist. 2002;44:A68. [Google Scholar]
  • 8.Yunomae K., Arima H., Hirayama F., Uekama K. Involvement of cholesterol in the inhibitory effect of dimethyl-β-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cells. FEBS Lett. 2003;536:225–231. doi: 10.1016/s0014-5793(03)00059-0. [DOI] [PubMed] [Google Scholar]
  • 9.Arima H., Yunomae K., Morikawa T., Hirayama F., Uekama K. Contribution of cholesterol and phospholipids to inhibitory effect of dimethyl-β-cyclodextrin on efflux function of P-glycoprotein and multidrug resistance-associated protein 2 in vinblastine-resistant Caco-2 cell monolayers. Pharm. Res. 2004;21:625–634. doi: 10.1023/b:pham.0000022409.27896.d4. [DOI] [PubMed] [Google Scholar]
  • 10.Nishino J., Moriyama S., Shiota S. Interaction of cholesterol with cyclodextrins in aqueous solution. Chem. Pharm. Bull. 2003;51:1253–1257. doi: 10.1248/cpb.51.1253. [DOI] [PubMed] [Google Scholar]
  • 11.Ory D.,S., Ottinger E.,A., Farhat N.,Y., King K.,A., Jiang X., Weissfeld L., Berry-Kravis E., Davidson C.,D., Bianconi S., Keener L.A., Rao R., Soldatos A., Sidhu R., Walters K.A., Xu X., Thurm A., Solomon B., Pavan W.,J., Machielse B.,N., Kao M., Silber S.,A., McKew J.C., Brewer C.,C., Vite C.,H., Walkley S.,U., Austin C.,P., Porter F.,D. Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial. Lancet. 2017;390:1758–1768. doi: 10.1016/S0140-6736(17)31465-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Motoyama K., Nishiyama R., Maeda Y., Higashi T., Ishitsuka Y., Kondo Y., Irie T., Era T., Arima H. Synthesis of multi-lactose-appended β-cyclodextrin and its cholesterol-lowering effects in Niemann-Pick type C disease-like HepG2 cells. Beilstein J. Org. 2017;13:10–18. doi: 10.3762/bjoc.13.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ikeda A., Iwata N., Hino S., Mae T., Tsuchiya Y., Sugikawa K., Hirano T., Haino T., Ohara K., Yamaguchi K. Liposome collapse resulting from an allosteric interaction between 2,6-dimethyl-β-cyclodextrins and lipids. RSC Adv. 2015;5:77746–77754. [Google Scholar]
  • 14.Fagoonee S., Pellicano R. Helicobacter pylori: molecular basis for colonization and survival in gastric environment and resistance to antibiotics. A short review. Infect. Dis. 2019;51:399–408. doi: 10.1080/23744235.2019.1588472. [DOI] [PubMed] [Google Scholar]
  • 15.Marchini A., d’Apolito M., Massari P., Atzeni M., Copass M., Olivieri R. Cyclodextrins for growth of Helicobacter pylori and production of vacuolating cytotoxin. Arch. Microbiol. 1995;164:290–293. doi: 10.1007/BF02529963. [DOI] [PubMed] [Google Scholar]
  • 16.Douraghi M., Kashani S.,S., Zeraati H., Esmaili M., Oghalaie A., Mohammadi M. Comparative evaluation of three supplements for Helicobacter pylori growth in liquid culture. Curr. Microbiol. 2009;60:254–262. doi: 10.1007/s00284-009-9534-4. [DOI] [PubMed] [Google Scholar]
  • 17.Shimomura H., Hosoda K., Hayashi S., Yokota K., Oguma K., Hirai Y. Steroids mediate resistance to the bactericidal effect of phosphatidylcholines against Helicobacter pylori. FEMS Microbiol. Lett. 2009;301:84–94. doi: 10.1111/j.1574-6968.2009.01807.x. [DOI] [PubMed] [Google Scholar]
  • 18.Hosoda K., Shimomura H., Hayashi S., Yokota K., Oguma K., Hirai Y. Anabolic utilization of steroid hormones in Helicobacter pylori. FEMS Microbiol. Lett. 2009;297:173–179. doi: 10.1111/j.1574-6968.2009.01685.x. [DOI] [PubMed] [Google Scholar]
  • 19.Hosoda K., Shimomura H., Hayashi S., Yokota K., Hirai Y. Steroid hormones as bactericidal agents to Helicobacter pylori. FEMS Microbiol. Lett. 2011;318:68–75. doi: 10.1111/j.1574-6968.2011.02239.x. [DOI] [PubMed] [Google Scholar]
  • 20.Shimomura H. In: Relationship between Steroid Hormones and Helicobacter pylori. Steroids-Clinical Aspect. Abdulijabbar H., editor. InTech; Riieka, Croatia: 2011. [Google Scholar]
  • 21.Shimomura H., Hosoda K., Hayashi S., Yokota K., Hirai Y. Phosphatidylethanolamine of Helicobacter pylori functions as a steroid-binding lipid in the assimilation of free cholesterol and 3β-hydroxl steroids into the bacterial cell membrane. J. Bacteriol. 2012;194:2658–2667. doi: 10.1128/JB.00105-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., Ulmer A.J., Zähringer U., Seydel U., Padova F.D., Schreier M., Brade H. Bacterial endotoxin: molecular relationship of structure to activity and function. FESEB J. 1994;8:217–225. doi: 10.1096/fasebj.8.2.8119492. [DOI] [PubMed] [Google Scholar]
  • 23.Guo L., Lim K.B., Gunn J.S., Bainbridge B., Darveau R.P., Hackett M., Miller S.I. Regulation of lipid A modification by Salmonella typhimurium virulence genes phoP-phoQ. Science. 1997;276:250–253. doi: 10.1126/science.276.5310.250. [DOI] [PubMed] [Google Scholar]
  • 24.Stead C.M., Beasley A., Cotter R.J., Trent M.S. Deciphering the unusual acylation pattern of Helicobacter pylori lipid. A. J. Bacteriol. 2008;190:7012–7021. doi: 10.1128/JB.00667-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Cullen T.,W., Giles D.,K., Wolf L.,N., Ecobichon C., Boneca I.,G., Trent M.,S. Helicobacter pylori versus the host: remodeling of the bacterial outer membrane is required for survival in the gastric mucosa. PLoS Pathog. 2011;7(12) doi: 10.1371/journal.ppat.1002454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Steimle A., Autenrieth I.B., Frick J.S. Structure and function: lipid A modification in commensal and pathogens. Int. J. Mrd. Microbiol. 2016;306:290–301. doi: 10.1016/j.ijmm.2016.03.001. [DOI] [PubMed] [Google Scholar]
  • 27.Shimomura H., Wanibuchi K., Hosoda K., Amgalanbaatar A., Masui H., Takahashi T., Hirai Y. Unique responses of Helicobacter pylori to exogenous hydrophobic compounds. Chem. Phys. Lipids. 2020 doi: 10.1016/j.chemphyslip.2020.104908. [DOI] [PubMed] [Google Scholar]
  • 28.Hirai Y., Haque M., Yoshida T., Yokota K., Yasuda T., Oguma K. Unique cholesteryl glucosides in Helicobacter pylori: composition and structural analysis. J. Bacteriol. 1995;177:5327–5333. doi: 10.1128/jb.177.18.5327-5333.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Shimomura H., Hayashi S., Yokota K., Oguma K., Hirai Y. Alteration in the composition of cholesteryl glucosides and other lipids in Helicobacter pylori undergoing morphological change from spiral to coccoid form. FEMS Microbiol. Lett. 2004;237:407–413. doi: 10.1016/j.femsle.2004.07.004. [DOI] [PubMed] [Google Scholar]
  • 30.Wunder C., Churin Y., Winau F., Warnecke D., Vieth M., Lindner B., Zähringer U., Mollenkopf H.J., Heinz E., Meyer T.F. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat. Med. 2006;12:1030–1038. doi: 10.1038/nm1480. [DOI] [PubMed] [Google Scholar]
  • 31.McGee D.J., George A.E., Trainor E.A., Horton K.E., Hildebrandt E., Testerman T.L. Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37. Agents Chemother. 2011;55:2897–2904. doi: 10.1128/AAC.00016-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Trainor E.A., Horton K.E., Savage P.E., Testerman T.L., McGee D.J. Role of the HefC efflux pump in Helicobacter pylori cholesterol-dependent resistance to ceragenins and bile salts. Infect. Immun. 2011;79:88–97. doi: 10.1128/IAI.00974-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Correia M., Casal S., Vinagre J., Seruca R., Figueiredo C., Touati E., Machado J.C. Helicobacter pylori’s cholesterol uptake impacts resistance to docosahexaenoic acid. Int. J. Med. Microbiol. 2014;304:314–320. doi: 10.1016/j.ijmm.2013.11.018. [DOI] [PubMed] [Google Scholar]
  • 34.Amgalanbaatar A., Shimomura H., Hosoda K., Hayashi S., Yokota K., Hirai Y. Antibacterial activity of a novel synthetic progesterone species carrying a linoleic acid molecule against Helicobacter pylori and the hormonal effect of its steroid on a murine macrophage-like cell line. J. Steroid Biochem. Mol. Biol. 2014;140:17–25. doi: 10.1016/j.jsbmb.2013.10.023. [DOI] [PubMed] [Google Scholar]
  • 35.Jan H.M., Chen Y.C., Shih Y.Y., Huang Y.C., Tu Z., Ingle A.B., Liu S.W., Wu M.S., G-Hague J., Mong K.K.T., Chen Y.R., Lin C.H. Metabolic labeling of cholesteryl glucosides in Helicobacter pylori reveals how the uptake of human lipids enhances bacterial virulence. Chem. Sci. 2016;7:6208–6216. doi: 10.1039/c6sc00889e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Saqui-Salces M., Rocha-Gutiérrez B.L., Barrios-Payán J.,A., Ruiz-Palacios G., Camacho-Arroyo I., Gamboa-Dominguez A. Effects of estradiol and progesterone on gastric mucosal response to early Helicobacter pylori infection in female gerbils. Helicobacter. 2006;11:123–130. doi: 10.1111/j.1523-5378.2006.00386.x. [DOI] [PubMed] [Google Scholar]
  • 37.Wang P., Ng Q.,X., Zhang H., Zhang B., Ong C.,N., He Y. Metabolite changes behind faster growth and less reproduction of Daphnia similis exposed to low-dose silver nanoparticles. Ectoxiol. Environ. Saf. 2018;163:266–273. doi: 10.1016/j.ecoenv.2018.07.080. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

No data was used for the research described in the article.

Articles from Heliyon are provided here courtesy of Elsevier

RESOURCES